Compare HUSA & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUSA | NATR |
|---|---|---|
| Founded | N/A | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 357.4M |
| IPO Year | N/A | N/A |
| Metric | HUSA | NATR |
|---|---|---|
| Price | $2.14 | $22.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $21.33 |
| AVG Volume (30 Days) | ★ 288.6K | 109.7K |
| Earning Date | 11-19-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | $225,678.00 | ★ $474,542,000.00 |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | N/A | $3.44 |
| P/E Ratio | ★ N/A | $27.77 |
| Revenue Growth | N/A | ★ 6.62 |
| 52 Week Low | $1.96 | $11.01 |
| 52 Week High | $12.70 | $22.80 |
| Indicator | HUSA | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 22.16 | 70.12 |
| Support Level | $1.96 | $20.34 |
| Resistance Level | $2.34 | $22.31 |
| Average True Range (ATR) | 0.35 | 0.80 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 5.17 | 97.28 |
Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.